Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOST: Nesiritide in ED Observation Unit for CHF
NCT00453453Phase 4Terminated
- Sponsor
- Emory University
- Start
- Mar 2007
- Primary completion
- Sep 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nesiritide in heart failure (HF), sponsored by Emory University. Primary endpoint: Number of subjects that return to the emergency department in 90 days. Started Mar 2007; status: terminated.
02
Drugs
nesiritide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00453453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453453.